Inactive Instrument

Orion Biotech Opportunities Corp. Stock

ORIA

KYG6780C1096

Chart Orion Biotech Opportunities Corp.

Duration

Period

Style

Dynamic Chart

Latest news about Orion Biotech Opportunities Corp.

Orion Biotech Opportunities Corp.(OTCPK:ORIA) dropped from NASDAQ Composite Index	23-04-28	CI
Orion Biotech Opportunities Corp. Auditor Raises 'Going Concern' Doubt	23-03-28	CI
Orion Biotech Opportunities Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Orion Biotech Opportunities Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12	CI
Orion Biotech Opportunities Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-11	CI
Orion Biotech Opportunities Corp. Reports Earnings Results for the Eleven Months Ended December 31, 2021	22-03-24	CI
Certain Class B Ordinary Shares of Orion Biotech Opportunities Corp. are subject to a Lock-Up Agreement Ending on 9-NOV-2021.	21-11-08	CI
Orion Biotech Opportunities Corp. has completed an IPO in the amount of $200 million.	21-05-12	CI
Orion Biotech Opportunities Corp. has filed an IPO in the amount of $200 million.	21-02-25	CI

More news

Press releases Orion Biotech Opportunities Corp.

Orion Biotech Opportunities : will redeem its Public Shares and will not consummate an initial business combination - Form 8-K	23-04-24	PU
ORION BIOTECH OPPORTUNITIES CORP. : Other Events, Financial Statements and Exhibits (form 8-K)	23-04-24	AQ
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-03-29	AQ
ORION BIOTECH OPPORTUNITIES CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-11-10	AQ
ORION BIOTECH OPPORTUNITIES CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-08-12	AQ

More press releases

Managers and Directors - Orion Biotech Opportunities Corp.

Managers	Title	Age	Since
Zuie Chin Huang FOU	Founder	58	21-02-04
Chrystyna Stecyk FOU	Founder	61	21-02-04
Mark Kayal DFI	Director of Finance/CFO	39	-

Members of the board	Title	Age	Since
Zuie Chin Huang FOU	Founder	58	21-02-04
Samuel Broder BRD	Director/Board Member	79	-
James Collins BRD	Director/Board Member	58	-

More insiders

Orion Biotech Opportunities Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company intends to focus on the biotechnology and life sciences industries. It has no operations and has generated no revenues.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+107.89%	4.54B
SCREAMING EAGLE ACQUISITION CORP.	+1.89%	1.01B
CHURCHILL CAPITAL CORP VII	+2.00%	980M
ILEARNINGENGINES, INC.	-35.43%	963M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+25.02%	809M
ARES ACQUISITION CORPORATION II	+1.63%	664M
E7 GROUP	+0.90%	612M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M

Shell Companies